机构地区:[1]School of Pharmaceutical Science,Medicinal Basic Research Innovation Center of Chronic Kidney Disease,Ministry of Education,Shanxi Medical University,Taiyuan 030001,Shanxi,China [2]Shanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing on Chronic Inflammation,Shanxi University of Chinese Medicine,Taiyuan 030619,Shanxi,China
出 处:《Journal of Chinese Pharmaceutical Sciences》2025年第1期41-54,共14页中国药学(英文版)
基 金:The National Natural Science Foundation of China(Grant No.82003770);the National Science and Technology Major Project of China(Grant No.2018ZX09711001-001-017);the Key Research and Development Plan of Shanxi Province(Grant No.202102130501005)。
摘 要:This study aimed to investigate the anti-inflammatory properties and underlying molecular mechanisms of 2,4',5'-trihydroxyl-5,2'-dibromo diphenylmethanone(LM49)using a carrageenan-induced paw edema model in mice,which serves as a well-established model for acute inflammation.Mice were randomly assigned into six groups,and acute inflammation was induced by injecting 1%carrageenan solution into the paw.To elucidate the anti-inflammatory effects and mechanisms of LM49,a comprehensive approach was employed,including pathology,transcriptomics,flow cytometry,RT-qPCR,Western blotting analysis,and molecular docking analysis.The results demonstrated that LM49 exerted a significant protective effect by reducing paw edema and lowering serum levels of pro-inflammatory cytokines IL-1βand TNF-a,while concurrently elevating anti-inflammatory cytokine IL-10 levels.Transcriptomic analysis identified 453 differentially expressed genes in the LM49-treated group.KEGG and GO enrichment analyses indicated that LM49 suppressed the NF-kB signaling pathway and modulated several other immuneinflammatory pathways.Molecular docking studies identified eight key targets of LM49 within the NF-kB signaling pathway.Furthermore,Western blotting analysis confirmed that LM49 inhibited the phosphorylation of p65 and IB-αand downregulated the expression of MYD88 and TLR4 in mouse paw tissues.These findings provided a foundational understanding of the anti-inflammatory effects and molecular mechanisms of LM49,paving the way for further in-depth studies in this field.本研究旨在评价2,4',5'-三羟基-5,2'-二溴二苯甲酮(LM49)对角叉菜胶诱导足肿胀模型小鼠的抗炎作用及潜在机制。小鼠随机分为6组,采用1%角叉菜胶溶液构建小鼠足肿胀模型。运用病理学、转录组学、流式细胞术、RT-qPCR、Western blot、分子对接等方法,研究LM49在角叉菜胶诱导的足肿胀模型中的抗炎作用及其机制。结果显示LM49可明显减轻小鼠足部水肿形成,降低血清促炎因子IL-1β和TNF-α水平,提高血清抑炎因子IL-10水平。转录组学分析显示,LM49组中有453个差异表达基因,KEGG和GO分析表明,LM49抑制NF-κB信号通路,并影响其他一些免疫炎症信号通路。分子对接揭示了LM49在NF-κB信号通路中的8个关键靶点。Westernblot结果证实,LM49能抑制小鼠足组织中p65和IκB-α的磷酸化,以及MYD88和TLR4的表达。本研究结果为进一步研究LM49的抗炎作用及分子机制提供了重要依据。
关 键 词:ANTI-INFLAMMATION TRANSCRIPTOMIC Molecular docking CARRAGEENAN 2 4' 5'-Trihydroxyl-5 2'-dibromo diphenylmethanone
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...